DrugPatentWatch Database Preview
Horizon Company Profile
What is the competitive landscape for HORIZON, and when can generic versions of HORIZON drugs launch?
HORIZON has seven approved drugs.
There are forty-seven US patents protecting HORIZON drugs.
There are three hundred and thirteen patent family members on HORIZON drugs in fifty-three countries and seventy-three supplementary protection certificates in fifteen countries.
Summary for Horizon
| International Patents: | 313 |
| US Patents: | 47 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
| Patent Litigation for Horizon: | See patent lawsuits for Horizon |
| PTAB Cases with Horizon as patent owner: | See PTAB cases with Horizon as patent owner |
Drugs and US Patents for Horizon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Horizon | VIMOVO | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 022511-001 | Apr 30, 2010 | RX | Yes | Yes | 9,220,698 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Horizon Pharma | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-003 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,394,407 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Horizon Pharma Usa | PROCYSBI | cysteamine bitartrate | CAPSULE, DELAYED RELEASE;ORAL | 203389-001 | Apr 30, 2013 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Horizon Pharma | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-001 | Jul 26, 2012 | AB | RX | Yes | No | 9,504,699 | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Horizon Pharma | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-002 | Jul 26, 2012 | AB | RX | Yes | No | 9,040,085 | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Horizon Pharma | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-002 | Jul 26, 2012 | AB | RX | Yes | No | 6,677,326 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Horizon | VIMOVO | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 022511-001 | Apr 30, 2010 | RX | Yes | Yes | 6,369,085*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Horizon
Paragraph IV (Patent) Challenges for HORIZON drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 800 mg/26.6 mg | ➤ Subscribe | 2011-12-06 |
| ➤ Subscribe | Oral Liquid | 1.1 g/mL | ➤ Subscribe | 2013-11-19 |
| ➤ Subscribe | Delayed-release Tablet | 375 mg/20 mg and 500 mg/20 mg | ➤ Subscribe | 2010-11-05 |
| ➤ Subscribe | Delayed-release Tablets | 1 mg, 2 mg, and 5 mg | ➤ Subscribe | 2012-11-26 |
International Patents for Horizon Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2640531 | ➤ Try a Free Trial |
| Norway | 2016023 | ➤ Try a Free Trial |
| European Patent Office | 2049123 | ➤ Try a Free Trial |
| Luxembourg | 92017 | ➤ Try a Free Trial |
| China | 1777412 | ➤ Try a Free Trial |
| Poland | 2330892 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 200301321 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Horizon Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 858 | Luxembourg | ➤ Try a Free Trial | 91858, EXPIRES: 20251105 |
| C0018 | France | ➤ Try a Free Trial | PRODUCT NAME: SACUBITRIL/VALSARTAN,SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN,C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL) PROPIONATE-(S)-3'-METHYL-2'-(PENTANOY(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE)DE TRISODIUM HEMIPENTAHYDRATE; REGISTRATION NO/DATE: EU/1/15/1058 20151123 |
| C/GB06/021 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201 |
| C0052 | France | ➤ Try a Free Trial | PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
| 5 | Finland | ➤ Try a Free Trial | |
| C0041 | France | ➤ Try a Free Trial | PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418 |
| C0055 | France | ➤ Try a Free Trial | PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
